This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.
Carrier (CARR) to Strengthen Refrigeration Segment Via EasyCube
by Zacks Equity Research
Carrier Global's (CARR) Carrier Commercial Refrigeration unveils EasyCube plug-in island cabinet which is likely to aid its momentum among various stores.
Earnings Growth & Price Strength Make Agilent Technologies (A) a Stock to Watch
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Agilent (A) Down 5.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Agilent Technologies (A) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Agilent (A) to Provide Genomics Innovation Via New Tie-Ups
by Zacks Equity Research
Agilent (A) collaborates with Amazon's AWS and NVIDIA to provide advanced analytical solutions in the genomics space.
Here's How Much a $1000 Investment in Agilent Technologies Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Agilent (A) to Attract Biopharma Customers With APC Tie-Up
by Zacks Equity Research
Agilent (A) collaborates with APC Ltd. to combine their technologies and develop unique workflows to cater to the needs of customers in the biopharmaceutical and pharmaceutical industry.
Here's Why Agilent Technologies (A) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Earnings Growth & Price Strength Make Agilent Technologies (A) a Stock to Watch
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
5 ETF Areas to Gain From Memorial Day 2022 & After
by Sanghamitra Saha
Memorial Day Weekend is around the corner and will start the summer travel season. These ETF areas are likely to gain this year from the Memorial Day event.
What Makes Agilent (A) a New Buy Stock
by Zacks Equity Research
Agilent (A) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street Analysts Predict a 31% Upside in Agilent (A): Here's What You Should Know
by Zacks Equity Research
The mean of analysts' price targets for Agilent (A) points to a 31.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Company News for May 26, 2022
by Zacks Equity Research
Companies In The News Are: DKS, A, DY, JWN.
Agilent (A) Q2 Earnings Surpass Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Agilent's (A) results for the fiscal second quarter reflect strong momentum in the pharma and chemical & energy market.
Agilent Technologies (A) Q2 Earnings Beat Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 1.80% and 0.33%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Agilent Technologies' (A) Q2 Earnings?
by Zacks Equity Research
Agilent Technologies' (A) fiscal second-quarter results are expected to reflect portfolio strength and momentum across all segments.
Agilent Technologies (A) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cognex Corporation (CGNX) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cognex Corporation (CGNX) delivered earnings and revenue surprises of 7.69% and 2.33%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Wolfspeed (WOLF) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Wolfspeed (WOLF) delivered earnings and revenue surprises of 14.29% and 1.28%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Ametek (AME) Tops Q1 Earnings Estimates
by Zacks Equity Research
Ametek (AME) delivered earnings and revenue surprises of 4.72% and 0.17%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
National Instruments (NATI) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
National Instruments (NATI) delivered earnings and revenue surprises of -6.82% and 4.69%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights Agilent Technologies, AMETEK, Fortive, and Cognex
by Zacks Equity Research
Agilent Technologies, AMETEK, Fortive, and Cognex Zacks Industry Outlook article.
4 Testing Equipment Stocks to Escape a Challenging Industry
by Shilpa Mete
Coronavirus--led disruptions are hurting the Zacks Electronics - Testing Equipment industry. However, industry participants like A, AME, FTV and CGNX are set to gain from 5G prospects.
Agilent (A) Boosts PD-L1 IHC 28-8 pharmDX Use in European Union
by Zacks Equity Research
Agilent Technologies (A) boosts its presence in the companion diagnostics market by expanding the use of PD-L1 IHC 28-8 pharmDx assay for esophageal squamous cell carcinoma treatment in the EU.